A rapid RNA extraction-free lateral flow assay for molecular point-of-care detection of SARS-CoV-2 augmented by chemical probes

Medicine & Life Sciences

• Severe Acute Respiratory Syndrome 100%
• Coronavirus 97%
• Point-of-Care Systems 87%
• RNA 53%
• Reverse Transcriptase Polymerase Chain Reaction 19%
• Cysteamine 13%
• Nucleic Acid Amplification Techniques 13%
• 6-carboxyfluorescein 13%
• Oligonucleotide Probes 12%
• Antisense Oligonucleotides 11%
• Biotin 10%
• Pandemics 10%
• Gold 9%
• Nanoparticles 8%
• Cysts 8%
• Complementary DNA 7%
• Costs and Cost Analysis 6%
• Delivery of Health Care 5%
• Equipment and Supplies 5%
• Genes 3%

Chemical Compounds

• Chain Reaction 76%
• 6-Carboxyfluorescein 56%
• Probe 47%
• Biotin 41%
• Complementary DNA 40%
• Nucleic Acid 32%
• Gold Nanoparticle 32%

Engineering & Materials Science

• Assays 90%
• Polymerase chain reaction 38%
• Biotin 22%
• Oligonucleotides 19%
• Nucleic acids 18%
• Genes 12%
• Costs 4%